NCT07320872Recruiting
Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris
Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris and Its Relation to Pathogenesis and Risk of the Disease
Source: ClinicalTrials.gov · Last updated 6 Jan 2026
Brief summary (registry, in English)
Psoriasis is a common immune-mediated inflammatory skin disease affecting at least 100 million individuals worldwide. In Egypt, the prevalence of psoriasis ranges between 0.19% and 3% of the Egyptian people. It is associated with poor quality of life, reduced life expectancy and multimorbidity including psoriatic arthritis, obesity and cardiovascular disease. Vaspin (VASP, SERPIN 12) is a recently discovered adipokine that has been isolated from the visceral adipose tissue of a rat model of type 2 diabetes. It is coded by the gene SERPNA12 located on the long arm of chromosome 14q32.13 and consists of six exons and five introns.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 21 Dec 2025
- Start date
- 10 Aug 2025
- Primary completion date
- 10 Aug 2026
- Lead sponsor
- Aswan University
- Diseases
- Psoriasis
- NCT number
- NCT07320872
What you commit to
- Study type: Observational
- Planned participants: 60
- From 10 Aug 2025 to the primary completion date, 10 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with chronic diseases: cardiac diseases, hepatic disorders, chronic renal failure or malignancies.
- Patients with associated inflammatory disease such as infections and autoimmune diseases.
Other
- Pregnancy and lactation.
Who the study is looking for
- Newly diagnosed cases or stopped treatment of at least 6 months of psoriasis patients.
- Pateints with any age and gender.
Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aswan University Hospital Coordinator of this site? Confirm its status | Aswān | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.